Skip to main content
. 2018 Oct 12;5(4):224–229. doi: 10.5152/eurjrheum.2018.18013

Table 1.

Inclusion and exclusion criteria

Inclusion criteria Exclusion criteria
Severe, primary, or secondary Raynaud’s phenomenon (intense and incapacitating pain) Active infection at the injection site
Presence of ulcers and/or necrosis Hypersensitivity to botulinum toxin or drug delivery vehicle
Distal capillary filling of >8 s Earlier thoracic sympathectomy
Refractory reaction to conventional medical treatments (calcium antagonists) Pregnant or breastfeeding
Absence of obstructive disease confirmed by Doppler echocardiography